Artificial intelligence (AI) is expected to revolutionise the practice of medicine. Recent advancements in the field of deep learning have demonstrated success in variety of clinical tasks: detecting diabetic retinopathy from images, predicting hospi...
Different embodiments of technology permeate all layers of public and private domains in society. In the public domain of aged care, attention is increasingly focused on the use of socially assistive robots (SARs) supporting caregivers and older adul...
I analyse an argument according to which medical artificial intelligence (AI) represents a threat to patient autonomy-recently put forward by Rosalind McDougall in the The argument takes the case of IBM Watson for Oncology to argue that such technol...
In contrast to Di Nucci's characterisation, my argument is not a technoapocalyptic one. The view I put forward is that systems like IBM's Watson for Oncology create both risks and opportunities from the perspective of shared decision-making. In this ...
Artificial intelligence (AI) is increasingly being developed for use in medicine, including for diagnosis and in treatment decision making. The use of AI in medical treatment raises many ethical issues that are yet to be explored in depth by bioethic...
Although the use of pet robots in senior living facilities and day-care centres, particularly for individuals suffering from dementia, has been intensively researched, the question of introducing pet robots into domestic settings has been relatively ...